alexa Circulating Vascular Endothelial Growth Factor In Type 2 Diabetes Mellitus With Diabetic Nephropathy
ISSN: 2161-0959

Journal of Nephrology & Therapeutics
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

12TH ANNUAL CONFERENCE ON Nephrology & Urology
JULY 06-07, 2017 KUALA LUMPUR, MALAYSIA

Alaa A Sabry
Mansoura University, Egypt
Posters & Accepted Abstracts: J Nephrol Ther
DOI: 10.4172/2161-0959-C1-043
Abstract
Mechanisms underlying the development of diabetic kidney disease are complex. Among the many potential pathogenic mechanisms responsible for the development of diabetic kidney disease, the angiogenic growth and survival factor, Vascular Endothelial Growth Factor (VEGF) has been suggested to be an important player. The aim of this study was to evaluate circulating vascular endothelial growth factor level in diabetic nephropathy and to assess whether its level is related to the severity of diabetic nephropathy in type 2 diabetic patients. 38 type 2 diabetic patients and 8 healthy subjects of matched age, sex and BMI served as a control group in the study. The studied patients were categorized into three groups according to urinary albumin excretion as follows: Group 1: Comprised of 13 normoalbumiuric (UAE <30 mg/24 h) type 2 diabetic patients; Group 2: Comprised of 12 microalbumiuric (UAE 30–299 mg/24 h) type 2 diabetic patients and; Group 3: Comprised of 13 macroalbumiuric (UAE ≥300 mg/24 h) type 2 diabetic patients. Sera were separated by centrifugation and kept frozen at (-20°C) for analysis of serum total VEGF by enzyme immunoassay (EIA) method using Accucyte® human VEGF kits supplied by Accucyte® (USA). Fundus examination, electrocardiograph and abdominal ultrasound were done. There was significant increase in serum VEGF in nephropathic group compared to non nephropathic group (7.546±3.579 versus 19.344±11.649, P=0.0001). There was significant increase in serum VEGF in macro-albuminuric subgroup compared to micro-albumiuric subgroup (26.046±11.973 versus 12.083±5.396, P=0.001). There was significant increase in serum VEGF in non nephropathic group, nephropathic group and in all patient series compared to control group (7.546±3.579, 19.344±11.649, 15.307±11.151 and 2.737±1.056 respectively). There was significant correlation between serum VEGF, UAE (P=0.69, R=0.0001), (serum creatinine (P=0.45, R=0.024). The results of the present study on a quiet homogeneous group of diabetics with regard to age, sex, BMI clarified that VEGF may be a good index for early detection and determination of the severity of diabetic nephropathy due to type 2 diabetes.
Biography

Email: asabry2040@yahoo.com

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

agriaquaculture@omicsonline.com

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

biochemjournals@omicsonline.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@omicsonline.com

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

chemistryjournals@omicsonline.com

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

clinicaljournals@omicsonline.com

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

engineeringjournals@omicsonline.com

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

nutritionjournals@omicsonline.com

1-702-714-7001Extn: 9042

General Science

Andrea Jason

generalscience@omicsonline.com

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

geneticsmolbio@omicsonline.com

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immunomicrobiol@omicsonline.com

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

materialsci@omicsonline.com

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

nursinghealthcare@omicsonline.com

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

medicaljournals@omicsonline.com

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuropsychology@omicsonline.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

pharmajournals@omicsonline.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@omicsonline.com

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords